Last updated on February 2017

Phase III, randomized, double-blind, active-controlled, parallel-group study, comparing the efficacy, safety and tolerability of the fixed dose combination of FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled ASTHMA.


Brief description of study

Phase III, randomized, double-blind, active-controlled, parallel-group study, comparing the efficacy, safety and tolerability of the fixed dose combination of FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled ASTHMA.

Detailed Study Description

This study is comparing a triple fixed-dose combination product compared to a dual fixed-dose combination product in patients with asthma not adequately controlled. This study is for adults age 18 and above.

Clinical Study Identifier: TX147792

Find a site near you

Start Over

Midwest Chest Consultants

330 First Capitol Drive, Suite 470 St. Charles, MO USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.